
<html>
<head>
<title>12222004 8K DOC</title>
</head>
<body bgcolor=white>
<font FACE="Times New Roman" SIZE="3">

<DIV align=left>
<B><HR align=left SIZE=2 width="100%"></B>
<B><HR align=left SIZE=2 width="100%"></B>
</DIV>



<B><P ALIGN="CENTER">UNITED STATES</P>
<P ALIGN="CENTER">SECURITIES AND EXCHANGE COMMISSION</P>
<FONT FACE="Times New Roman Bold,Times New Roman" SIZE=2><P
ALIGN="CENTER">Washington, DC</FONT><FONT SIZE=2> 20549</P>
</FONT><FONT SIZE=5><P ALIGN="CENTER">FORM 8-K</P>
</B></FONT>
<B><P ALIGN="CENTER">CURRENT REPORT</P>
<P ALIGN="CENTER">Pursuant to Section 13 or 15(d) of the <BR>
Securities Exchange Act of 1934</P>
</B>
<FONT SIZE=2><P ALIGN="CENTER">Date of Report (Date of earliest event
reported):</FONT> <B><FONT SIZE=2>December 17, 2004</P>
</B></FONT>


<B><FONT SIZE=6><P ALIGN="CENTER">PHARMACYCLICS, INC.</B></FONT>




<FONT SIZE=1><P ALIGN="CENTER">(Exact Name of Registrant as Specified in its
Charter)</FONT>




<TABLE CELLSPACING=0 BORDER=0 WIDTH=637>
<TR><TD WIDTH="38%" VALIGN="TOP">&nbsp;</TD>
<TD WIDTH="38%" VALIGN="TOP">&nbsp;</TD>
<TD WIDTH="25%" VALIGN="TOP">&nbsp;</TD>
</TR>
<TR><TD WIDTH="38%" VALIGN="TOP">
<B><FONT SIZE=2><P ALIGN="CENTER">Delaware</B></FONT></TD>
<TD WIDTH="38%" VALIGN="TOP">
<B><FONT SIZE=2><P ALIGN="CENTER">000-26658</B></FONT></TD>
<TD WIDTH="25%" VALIGN="TOP">
<B><FONT SIZE=2><P ALIGN="CENTER">94-3148201</B></FONT></TD>
</TR>
<TR><TD WIDTH="38%" VALIGN="TOP">
<FONT SIZE=1><P ALIGN="CENTER">(State or Other Jurisdiction</FONT></TD>
<TD WIDTH="38%" VALIGN="TOP">
<FONT SIZE=1><P ALIGN="CENTER">(Commission</FONT></TD>
<TD WIDTH="25%" VALIGN="TOP">
<FONT SIZE=1><P ALIGN="CENTER">(IRS Employer</FONT></TD>
</TR>
<TR><TD WIDTH="38%" VALIGN="TOP">
<FONT SIZE=1><P ALIGN="CENTER">of Incorporation)</FONT></TD>
<TD WIDTH="38%" VALIGN="TOP">
<FONT SIZE=1><P ALIGN="CENTER">File Number)</FONT></TD>
<TD WIDTH="25%" VALIGN="TOP">
<FONT SIZE=1><P ALIGN="CENTER">Identification No.)</FONT></TD>
</TR>
</TABLE>

<P ALIGN="CENTER"></P>
<TABLE CELLSPACING=0 BORDER=0 WIDTH=637>
<TR><TD WIDTH="75%" VALIGN="TOP">&nbsp;</TD>
<TD WIDTH="25%" VALIGN="TOP">&nbsp;</TD>
</TR>
<TR><TD WIDTH="75%" VALIGN="TOP">
<B><FONT SIZE=2><P ALIGN="CENTER">995 E. Arques Avenue<br>
Sunnyvale, California  </B></FONT></TD>
<TD WIDTH="25%" VALIGN="TOP">
<B><FONT SIZE=2><P ALIGN="CENTER">94085-4521</B></FONT></TD>
</TR>
<TR><TD WIDTH="75%" VALIGN="TOP" HEIGHT=19>
<FONT SIZE=1><P ALIGN="CENTER">(Address of Principal Executive
Offices)</FONT></TD>
<TD WIDTH="25%" VALIGN="TOP" HEIGHT=19>
<FONT SIZE=1><P ALIGN="CENTER">(Zip Code)</FONT></TD>
</TR>
</TABLE>

<P ALIGN="CENTER"></P>
<FONT SIZE=2><P ALIGN="CENTER">Registrant's telephone number, including area
code: <B>(408) 774-0330</P>
</B></FONT>




<B><FONT SIZE=2><P ALIGN="CENTER">Not Applicable</B></FONT><br>


<FONT SIZE=1>Former Name or Former Address, if Changed Since
Last Report.)</FONT></P>





<FONT SIZE=2><P ALIGN="CENTER">&nbsp;</P>
<P>Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (<I>see</I> General Instruction A.2. below):</P>
<P>[ ] Written communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425)</P>
<P>[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17
CFR 240.14a-12)</P>
<P>[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))</P>
<P>[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))</P>
<B>
</B></FONT><P>&nbsp;</P>

<P style="PAGE-BREAK-BEFORE: always" align=left>


<P>&nbsp;</P>
<B><P>&nbsp;</P>
<FONT SIZE=2><P>Item 1.01 Entry Into Material Definitive Agreement</P>

</B><P>On December 17, 2004, our stockholders approved the
Pharmacyclics, Inc. (the &quot;Company&quot;) 2004 Equity Incentive Award Plan
(the &quot;2004 Plan&quot;).  The 2004 Plan is intended to supersede the
Company's 1995 Stock Option Plan, the Non-Employee Directors Stock Option Plan
and the 1992 Stock Option Plan (the &quot;Prior Plans&quot;), which were
previously approved by our stockholders.  No further grants or awards will be
issued from the Prior Plans. The remaining shares of the Company's common stock
not subject to outstanding awards under the Prior Plans and an additional
600,000 shares will be available for issuance under the 2004 Plan. Additionally,
if options granted under the Prior Plans expire or otherwise terminate without
being exercised, all shares upon the expiration of such outstanding options will
become available for future issuance under the 2004 Plan. </P>
<P>&#9;The 2004 Plan provides the Company with the ability to grant specified
types of equity awards including incentive stock options, non-qualified stock
options, restricted stock, stock appreciation rights, performance shares,
deferred stock, restricted stock units, dividend equivalents, performance stock
units and other stock based awards. Company employees are eligible to receive
all types of awards approved under the 2004 Plan. Directors and consultants of
the Company are eligible to receive all types of approved awards except for
incentive stock options. The Compensation Committee or its delegate will
determine which employees and consultants will receive awards under the 2004
Plan and the terms and conditions of such awards, within certain limitations set
forth in the 2004 Plan.  Upon a change in control or corporate transaction, each
outstanding award under the 2004 Plan shall automatically be vested with respect
to fifty percent (50%) of the unvested shares of Common Stock or Option Shares. To the extent the
remaining fifty percent (50%) of unvested awards are not assumed or replaced by
the successor corporation, they will also be accelerated.  If the successor
corporation assumes or replaces the remaining fifty percent (50%) of the
unvested awards, such awards will not automatically vest.  However, if a
participant is involuntarily terminated during the twelve (12)&nbsp;month period
following such change in control or corporate transaction, then the remaining
fifty percent (50%) of such participant's award will immediately vest and become
exercisable.  Under the 2004 Plan, the Company's non-employee directors will
receive certain automatic, non-discretionary grants of non-qualified stock
options.  Specifically, each new non-employee director will receive an option to
purchase 10,000 shares as of the date he or she first becomes a non-employee
director which will vest in equal annual installments over five (5)&nbsp;years
(the &quot;Initial Option&quot;).  In addition, on the date of each annual
meeting, each individual re-elected as a non-employee director will receive an
automatic option grant to purchase an additional 7,500 shares which vests in
equal monthly installments over twelve (12)&nbsp;months following the date of
grant (the &quot;Annual Option&quot;).  In the event of a non-employee
director's termination of membership on the Company's board due to death or
disability or upon a change in control or corporate transaction of the Company,
any outstanding Initial Options or Annual Options shall immediately vest in
full.  Certain awards under the 2004 Plan may be designed to constitute
&quot;performance-based compensation&quot; for purposes of Section 162(m) of the
Internal Revenue Code of 1986, as amended.  The above summary is further
qualified by the 2004 Plan, which is incorporated herein by reference to Exhibit
B to the Company's Schedule 14A filed with the Securities and Exchange
Commission on November 11, 2004.</P>

<P>&nbsp;</P>
<P>&nbsp;</P>
<B><P>Item 9.01 Financial Statements and Exhibits</P>
</B></FONT>
<TABLE CELLSPACING=0 BORDER=0 CELLPADDING=7 WIDTH=511>
<TR><TD WIDTH="38%" VALIGN="TOP">
<B><FONT SIZE=2><P><BR>
Exhibit<BR>
<U>&nbsp;&nbsp;No.&nbsp;&nbsp;</B></U></FONT></TD>
<TD WIDTH="62%" VALIGN="TOP">
<B><FONT SIZE=2><P><BR>
<BR>
<U>Description</B></U></FONT></TD>
</TR>
<TR><TD WIDTH="38%" VALIGN="TOP">
<FONT SIZE=2><P>99.1</FONT></TD>
<TD WIDTH="62%" VALIGN="TOP">
<B><FONT SIZE=2><P>Form of Option Agreement for 2004 Plan</P>
</B></FONT></TD>
</TR>
<TR><TD WIDTH="38%" VALIGN="TOP">
<FONT SIZE=2><P>99.2</FONT></TD>
<TD WIDTH="62%" VALIGN="TOP">
<B><FONT SIZE=2><P>Form of Non-Employee Director Option Agreement for 2004
Plan</B></FONT></TD>
</TR>
</TABLE>

<P style="PAGE-BREAK-BEFORE: always" align=left>



<B><FONT SIZE=2>
<P>&nbsp;</P>
<P ALIGN="CENTER">&nbsp;</P>
<P ALIGN="CENTER">SIGNATURES</P>
</B>
<P>Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.</P>

<DIR>
<DIR>
<DIR>
<DIR>
<DIR>
<DIR>
<DIR>
<DIR>
<DIR>
<DIR>
<DIR>
<DIR>




<P>&#9;PHARMACYCLICS, INC.</P>

</DIR>
</DIR>
</DIR>
</DIR>
</DIR>
</DIR>
</DIR>
</DIR>
</DIR>
</DIR>
</DIR>
</DIR>






<P>Date:  December 17, 2004<br>

<DIR>
<DIR>
<DIR>
<DIR>
<DIR>
<DIR>
<DIR>
<DIR>
<DIR>
<DIR>
<DIR>
<DIR>






By:&#9;<U>/S/  LEIV LEA&#9;&#9;&#9;</P>
</U><P>&#9;&#9;<I>Name:</I>&#9;Leiv Lea<br>
<I>Title:</I>&#9;Vice President, Finance and<br>
Administration and CFO and<br>
Secretary</P>

</DIR>
</DIR>
</DIR>
</DIR>
</DIR>
</DIR>
</DIR>
</DIR>
</DIR>
</DIR>
</DIR>
</DIR>


<P style="PAGE-BREAK-BEFORE: always" align=left>



<P>&nbsp;</P>
<P>&nbsp;</P>
</FONT><B><P ALIGN="CENTER">EXHIBIT INDEX</B><br>


<TABLE CELLSPACING=0 BORDER=0 CELLPADDING=7 WIDTH=487>
<TR><TD WIDTH="40%" VALIGN="TOP">
<B><P><BR>
Exhibit<BR>
<U>&nbsp;&nbsp;No.&nbsp;&nbsp;</B></U></TD>
<TD WIDTH="60%" VALIGN="TOP">
<B><P><BR>
<BR>
<U>Description</B></U></TD>
</TR>
<TR><TD WIDTH="40%" VALIGN="TOP">
<P>99.1</TD>
<TD WIDTH="60%" VALIGN="TOP">
<B><P>Form of Option Agreement for 2004 Plan</B></TD>
</TR>
<TR><TD WIDTH="40%" VALIGN="TOP">
<P>99.2</TD>
<TD WIDTH="60%" VALIGN="TOP">
<B><P>Form of Non-Employee Director Option Agreement for 2004 Plan</B></TD>
</TR>
</TABLE>


<P>&nbsp;</P>
<FONT SIZE=3><P ALIGN="CENTER">&nbsp;</P>
<P>&nbsp;</P></FONT>


</body>
</html>

